Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug developmen ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests ...
As a researcher, I still remember the discomfort I felt every time I had to sacrifice laboratory animals for an experiment.
This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results